Alexza Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
MOUNTAIN VIEW, Calif., Sept. 15, 2011 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the company will participate in the Sixth Annual JMP Securities Healthcare Conference, being held in New York, New York, September 27 - 28, 2011. The Alexza corporate presentation will be Wednesday, September 28, 2011 at 10:30 am ET. The presentation will be webcast live.
To access the presentation via the Web, please go to the Investor Relations tab at www.alexza.com or directly at http://wsw.com/webcast/jmp14/alxa/. A replay of the webcast will be available approximately 24 hours after the live presentation and archived for 14 days.
About Alexza Pharmaceuticals, Inc.
Alexza is a pharmaceutical company focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions. Alexza's technology, the Staccato® system, vaporizes unformulated drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. (Click here to see an animation of how the Staccato system works.)
Adasuve™ (Staccato loxapine), Alexza's lead program, is being developed for the rapid treatment of agitation in adults with schizophrenia or bipolar disorder. Alexza has completed and announced positive results from both of its Phase 3 clinical trials and initially submitted the ADASUVE NDA in Dece